Sex hormones associated with subclinical kidney damage and atherosclerosis in South African men: The SABPA study

Journal of Hypertension

Volumn 30, Issue 12, 2012, Pages 2387-2394

  Malan, Nico T ^a   Hamer, Mark ^a,b   Lambert, Gavin W ^c   Schutte, Aletta E ^a   Huisman, Hugo W ^a   Van Rooyen, Johannes M ^a   Mels, Catharina M ^a   Smith, Wayne ^a   Fourie, Carla M T ^a   Schutte, Rudolph ^a   Kruger, Ruan ^a   Malan, Leoné ^a  

^a NORTH WEST UNIVERSITY   (South Africa)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c MONASH UNIVERSITY   (Australia)

Author keywords

Africans; albumin to creatinine ratio; atherosclerosis; estradiol; sex hormones; testosterone

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN; COTININE; CREATININE; ESTRADIOL; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; BLOOD PRESSURE MONITORING; BLOOD SAMPLING; CARDIOVASCULAR RISK; CAUCASIAN; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; CREATININE URINE LEVEL; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; ESTRADIOL BLOOD LEVEL; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HEART RATE; HUMAN; HUMAN TISSUE; KIDNEY INJURY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SOUTH AFRICA; SYSTOLIC BLOOD PRESSURE; TESTOSTERONE BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL; URINALYSIS; URINE LEVEL;

EID: 84870242566     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0b013e3283599bb5     Document Type: Article

References (47)

1. Opie LH, Seedat YK. Hypertension in Sub-Saharan populations. Circulation 2005; 112:3562-3568.
2. Torkler S, Wallaschofski H, Baumeister SE, Völzke H, Dörr M, Felix S, et al. Inverse association between total testosterone concentrations, incident hypertension and blood pressure. AgingMale 2011; 14:176-182.
3. Yasuda M, Furuya K, Yoshii T, Ide H, Muto S, Horie S. Low testosterone level of middle-aged men: the association between low testosterone levels and quality-of-life. J Mens Health Gend 2007; 4:149-155.
4. Kaufman JM, Vermeulen A. The decline of androgen levels in elderly men and its clinical and therapeutic implications. Endocr Rev 2005; 26:833-876.
5. Jones TH. Testosterone deficiency: a risk factor for cardiovascular disease? Trends Endocrin Met 2010; 21:496-503.
6. Cohen PG. Aromatase, adiposity, aging and disease. The hypogonadalmetabolic-atherogenic-disease and aging connection. Med Hypotheses 2001; 56:702-708.
7. Maric C, Forsblom C, Thorn L, Wadén J, Groo P-H. Association between testosterone, estradiol and sex hormone binding globulin levels in men with type 1 diabetes with nephropathy. Neurology 2010; 75:772-778.
8. TivestenA , Mellström D, Jutbergher H, Fagerberg B, Lernfelt B, Orwoll E, et al. Low serum testosterone and high serum estradiol associate with lower extremity peripheral arterial disease in elderly men. J Am Coll Cardiol 2007; 50:1070-1076.
9. YeapBB,Hyde Z, AlmeidaOP,NormanPE,Chubb SAP,Jamrozik K, et al. Lower testosterone levels predict incident stroke and transient ischemic attack in older men. J Clin Endocrinol Metab 2009; 94:2353-2359.
10. Corona G, Rastrelli G, Vignozzi L, Mannucci E, Maggi M. Testosterone, cardiovascular disease and the metabolic syndrome. Best Pract Res Clin Endocrinol Metab 2011; 25:337-353.
11. Tivesten A, Hulthe J, Wallenfeldt K, Wikstrand J, Ohlsson C, Fagerberg B. Circulating estradiol is an independent predictor of progression carotid intima-media thickness in middle-aged men. J Clin Endocrin Metab 2006; 91:4433-4437.
12. Gerstein HC, Mann JF, Yi Q, Zinman B, Dinneen SF, Hoogwerf B, et al. Albuminuria and risk of cardiovascular, death, and heart failure in diabetic and nondiabetic individuals. JAMA 2001; 286:421-426.
13. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, et al. 2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007; 25:1105-1187.
14. Baylis C. Changes in renal hemodynamics and structure in the aging kidney; sexual dimorphism and the nitric oxide system. Exp Gerontol 2005; 40:271-278.
15. American Diabetes Association. Nephropathy in diabetes (Position Statement). Diabetes Care 2004; 27 (Suppl 1):S79-S83.
16. Gerber LM, Schwartz JE, Pickering TG. Albumin-to-creatinine ratio predicts change in ambulatory blood pressure in normotensive persons: a 7.5 year prospective study. Am J Hypertens 2006; 19:315-321.
17. Wang TJ, Evans JC, Meigs JB, Rifai N, Fox CS, D'Agostino RB, et al. Lowgrade albuminuria and the risks of hypertension and blood pressure progression. Hypertension 2005; 111:1370-1376.
18. Clausen P, Jensen JS, Jensen G, Borch-Johnsen K, Feldt-Rasmussen B. Elevated urinary albumin excretion is associated with impaired arterial dilatory capacity in clinically healthy subjects. Circulation 2001; 103:1869-1874.
19. Lopes RAM, Neves KB, Carneiro FS, Tostes RC. Testosterone and vascular function in aging. Front Physiol 2012; 3:1-9.
20. Ä rnlöv J, Evans JC, Meigs JB, Wang TJ, Fox CS, Levy D, et al. Low-grade albuminuria and incidence of cardiovascular disease events in nonhypertensive and nondiabetic individuals: the Framingham study. Circulation 2005; 112:969-975.
21. Maric C, Forsblom C, Thorn L, Wadén J, Groo P-H. Association between testosterone, estradiol and sex hormone binding globulin levels in men with type 1 diabetes with nephropathy. Neurology 2010; 75:772-778.
22. Maric C, Xu Q, Sandberg K, Hinojosa-Laborde C. Age-related renal disease in female Dahls salt-senitive rats is attenuated with 17(-estradiol supplementation by modulating nitric oxide synthase expression. Gend Med 2008; 5:147-159.
23. Meng X, Dai X, Liao T-D, D'Ambrosio M, Wang F, Yang JJ, et al. Dosedependent toxic effects of high dose estrogen on renal and cardiac injury in surgically postmenopausal mice. Life Sci 2011; 88:178-186.
24. Klippel NJ, Heil DP. Validation of energy expenditure prediction algorithms in adults using the Actical electronic activity monitor. Med Sci Sports Exerc 2003; 35:S284.
25. Jarvis MJ, Tunstall-Pedoe H, Feyerabend C, Vesey C, Saloojee Y. Comparison of tests used to distinguish smokers from nonsmokers. Am J Public Health 1987; 77:1435-1438.
26. Jarvis MJ, Feyerabend C, Bryant A, Hedges B, Primatesta P. Passive smoking in the home: plasma cotinine concentrations in nonsmokers with smoking partners. Tob Control 2001; 10:368-374.
27. Sharpe PC. Biochemical detection and monitoring of alcohol abuse and abstinence. Ann Clin Biochem 2001; 38:652-664.
28. Marfell-Jones M, Olds T, Steward A, Carter JEL. International standards for anthropometric assessment. Potchefstroom, ISAK, 2006, p. 137.
29. Mosteller RD. Simplified calculation of body-surface area. N Engl J Med 317; 1987:1098.
30. Hadaegh F, Zabetian A, Sarbakhsh P, Khalili D, James WPT, Azizi F. Appropriate cutoff values of anthropometric variables to predict cardiovascular outcomes: 7.6 years follow-up in an Iranian population. Int J Obes 2009; 33:1437-1445.
31. de Ronde W, van der Schouw YT, Muller M, Grobbee DE, Gooren LJ, Pols HA, et al. Associations of sex-hormone-binding globulin (SHBG) with non-SHBG-bound levels of testosterone and estradiol in independently living men. J Clin Endocrin Metab 2005; 90:157-162.
32. Stein JH, Korcarz CE, Hurst RT, Lonn E, Kendall CB, Mohler ER, et al. Use of Carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: a Consensus Statement from the American Society of Echocardiography Carotid Intima-Media Thickness Task Force. J Am Soc Echocardiogr 2008; 21:93-111.
33. Liang YL, Teede H, Kotsoupoulos D, Shiel L, Cameron JD, Dart AM, McGrath BP. Noninvasive measurements of arterial structure and function: repeatability, interrelationships and trial samples size. Clin Sci 1998; 95:669-679.
34. Hamer M, Malan L, Schutte AE, Huisman HW, vanRooyen JM, Schutte R, et al. Conventional and behavioural risk factors explain differences in sub-clinical vascular disease between black and Caucasian South Africans: the SABPA study. Atherosclerosis 2011; 215:237-242.
35. Kluger J. Blowing a gasket. Time 2004; 164:34-40.
36. Hitha B, Pappachan JM, Pillai HB, Sujathan P, Ramakrishna CD, Jayaprakash K, et al. Microalbuminuria in patients with essential hypertension and its relationship to target organ damage: an Indian experience. Saudi J Kidney Dis Transpl 2008; 19:411-419.
37. Svartberg J, von Mühlen D, Mathiesen E, Joakimsen O, Bønaa KH, Stensland-Bugge E. Low testosterone levels are associated with carotid atherosclerosis in men. J Intern Med 2006; 259:76-582.
38. Platz E. Low testosterone and risk of premature death in older men: analytical and preanalytical issues in measuring circulating testosterone. Clin Chem 2008; 54:1110-1112.
39. Simon D, Nahoul K, Charles MA. Sex hormones, aging, ethnicity and insulin sensitivity in men: an overview of the TELECOM study. In: Vermeulen A, Oddens BJ, editors. Androgens and the aging male. 1st ed. New York; Parthenon Publishing; 1996. pp. 85-102.
40. Muneer A. Hypogonadism: an underdiagnosed condition. Trends Urol Gynaecol Sex Health 2010; 15:14-17.
41. Brosius FC III, Hostetter TH, Kelepouris E, Mitsnefes MM, Moe SM, Moore MA, et al. Detection of chronic kidney disease in patients with or at increased risk of cardiovascular disease: a science advisory from the American Heart Association Kidney and Cardiovascular Disease Council; the Councils on High Blood Pressure Research, Cardiovascular Disease in the Young, and Epidemiology and Prevention; and the Quality of Care and Outcomes Research Interdisciplinary Working Group-developed in collaboration with the National Kidney Foundation. Hypertension 2006; 48:751-755.
42. Aminbakhsh A, Mancini GB. Carotid intimae-media thickness measurements: what defines an abnormality? Clin Invest Med 1999; 22:149-157.
43. Mattix HJ, Hsu C-Y, Shaykevich S, Curhan G. Use of albumin/creatinine ratio to detect albuminuria: implications of sex and race. J Am Soc Nephrol 2002; 13:1034-1039.
44. Caló LA, Davis PA, Palatini P, Semplicini A, Pessina AC. Urinary albumin excretion, endothelial dysfunction and cardiovascular risk: study in Bartter's/Gitelman's syndromes and relevance for hypertension. J Hum Hypertens 2007; 21:904-906.
45. Calvano CJ, LeFevre R, Mankes RF, Reddy PP, Moran ME, Hoar RM, et al. The incidence of renal anomalies at full termin fetal rats is synergistically increased by estradiol (but not testosterone) supplementation on day 18 of alcoholic gestation. J Pediatr Surg 1997; 32:1302-1306.
46. Manigrasso MB, Sawyer RT, Hutchens ZM Jr, Flynn ER, Maric-Bilkan C. Combined inhibition of aromatase and dihydrotestosterone supplementation attenuates renal injury in male streptozotocin (STZ)-induced diabetic rats. Am J Physiol Renal Physiol 2012; 302:F1203-F1209.
47. Reckelhoff JF, Yanes LL, Iliescu R, Fortepiani LA, Granger JP. Testosterone supplementation in aging men and women: possible impact on cardiovascular-renal disease. Am J Physiol Renal Physiol 2005; 289:F941-F948.